(NOVO-B) Novo Nordisk - Performance -53.7% in 12m
NOVO-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
42.04%
#10 in Peer-Group
Rel. Strength
8.44%
#7016 in Stock-Universe
Total Return 12m
-53.68%
#135 in Peer-Group
Total Return 5y
118.16%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 18.4 |
| P/E Forward | 16.6 |
| High / Low | DKK |
|---|---|
| 52 Week High | 960.48 DKK |
| 52 Week Low | 390.00 DKK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 38.63 |
| Buy/Sell Signal +-5 | -2.28 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NOVO-B (-53.7%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: NOVO-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NOVO-B
| Total Return (including Dividends) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -15.05% | 3.15% | 4.01% |
| 3 Months | 4.44% | 17.08% | 17.14% |
| 12 Months | -53.68% | -11.14% | 13.46% |
| 5 Years | 118.16% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -54.2% | 52.1% | 90.3% |
| 3 Months | 53.4% | 79.4% | 97.5% |
| 12 Months | -94.8% | -87.4% | 46.4% |
| 5 Years | 88.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th14.50 | -17.64% | -18.32% |
| 3 Month | %th31.00 | -10.80% | -10.85% |
| 12 Month | %th33.50 | -47.88% | -59.18% |
| 5 Years | %th95.50 | 179.54% | 2.55% |
FAQs
Does Novo Nordisk (NOVO-B) outperform the market?
No,
over the last 12 months NOVO-B made -53.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months NOVO-B made 4.44%, while XBI made 17.08%.
Performance Comparison NOVO-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NOVO-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1% | -19.1% | -35.1% | -67% |
| US NASDAQ 100 | QQQ | -0.9% | -19.3% | -37.1% | -67% |
| German DAX 40 | DAX | -1.3% | -16.3% | -47.2% | -84% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.2% | -19.6% | -39.6% | -72% |
| Hongkong Hang Seng | HSI | -1.9% | -17.9% | -57.1% | -89% |
| India NIFTY 50 | INDA | 0.4% | -14.2% | -35.6% | -51% |
| Brasil Bovespa | EWZ | 3.2% | -14.4% | -50.2% | -55% |
NOVO-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.4% | -16.8% | -38.4% | -77% |
| Consumer Discretionary | XLY | -1.9% | -18.4% | -27.4% | -72% |
| Consumer Staples | XLP | 1.1% | -14.9% | -34.2% | -61% |
| Energy | XLE | -3.9% | -19.2% | -27.6% | -56% |
| Financial | XLF | 0.5% | -17.7% | -37.4% | -79% |
| Health Care | XLV | -1.1% | -15.1% | -23.6% | -47% |
| Industrial | XLI | -1.4% | -19.5% | -41% | -77% |
| Materials | XLB | -1.7% | -19.5% | -35.7% | -58% |
| Real Estate | XLRE | -0.7% | -14.9% | -33.6% | -62% |
| Technology | XLK | -0.9% | -21.7% | -40.2% | -65% |
| Utilities | XLU | -1.1% | -17.7% | -39.1% | -74% |
| Aerospace & Defense | XAR | -1.6% | -21.9% | -55.1% | -103% |
| Biotech | XBI | -4.6% | -18.2% | -24.9% | -43% |
| Homebuilder | XHB | -4.1% | -23.8% | -28.5% | -53% |
| Retail | XRT | -0.9% | -18.3% | -30.3% | -60% |
NOVO-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.6% | -18.4% | -21.2% | -49% |
| Natural Gas | UNG | 0.8% | -8.6% | -9.1% | -52% |
| Gold | GLD | -1.1% | -15.3% | -53% | -92% |
| Silver | SLV | -5.3% | -21.4% | -57.1% | -76% |
| Copper | CPER | -11.3% | -30% | -54.7% | -77% |
NOVO-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.1% | -15% | -29.8% | -49% |
| iShares High Yield Corp. Bond | HYG | -0.4% | -16.2% | -32.1% | -63% |